GLP-1 Agonists: Clinical Evidence for Weight Management
GLP-1 Clinical Relevance #47Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic NewsObservationalMetabolic SyndromeSweetenerEndocrinologyAdults with Metabolic…
GLP-1 Clinical Evidence: Insulin Resistance in Childhood Obesity
GLP-1 Clinical Relevance #44Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Longitudinal StudyCohort StudyInsulin ResistanceChildhood ObesityPediatric…
GLP-1 Clinical Evidence: Adolescent Metabolic Health
GLP-1 Clinical Relevance #45Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Consensus StatementObservationalAdolescent Metabolic HealthType 2 Diabetes…
Tirzepatide vs Liraglutide Clinical Research Comparison
GLP-1 Clinical Relevance #47Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Clinical CommentaryObservationalObesityLiraglutideTirzepatideGLP-1 Receptor…
GLP-1 Receptor Agonist Evidence: Beyond Obesity & Diabetes
GLP-1 Clinical Relevance #41Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical TrialPhase 3 TrialAlzheimer’s DiseaseSemaglutideNeurologyAdults with Cognitive…
